US Patents and Regulatory Information for REVLIMID
| Applicant | Tradename | Approval Date |
|---|---|---|
| Celgene | REVLIMID | Dec 27, 2005 |
| Celgene | REVLIMID | Jun 29, 2006 |
| Celgene | REVLIMID | Jun 5, 2013 |
| >Applicant | >Tradename | >Approval Date |
Is Revlimid under patent?
Revlimid is currently protected by 12 patents, including one that expires in 2019 and another—covering the crystal polymorph form of the drug—that only expires in 2026 and others are pending.
How long has Revlimid been on the market?
Revlimid in combination with dexamethasone was first approved by the U.S. Food and Drug Administration (FDA) in 2006 for multiple myeloma patients who have had at least one prior treatment.
Is there generic Revlimid?
The product is the generic of Celgene’s Revlimid. With this approval, Dr. Reddy’s is eligible for 180 days of generic drug exclusivity for lenalidomide capsules, 2.5 mg and 20 mg. Revlimid is used to treat adult patients with multiple myeloma.
Who invented Revlimid?
When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006, the price was $6,195 for 21 capsules, a month’s supply. By the time David Mitchell started taking Revlimid in November 2010, Celgene had bumped the price up to about $8,000 a month.
Who is the manufacturer of Revlimid?
Summit, New Jersey, U.S. Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
Where is Revlimid manufactured?
Lenalidomide, manufactured by Celgene Corporation, is marketed in China by BeiGene.
Who created Revlimid?
What is the monthly cost of Revlimid?
Celgene launched Revlimid in 2005 at a price of $215 per pill. After more than 20 price hikes, the drug now costs $763 per pill, or $16,023 per month.
When does Bystolic patent expire?
Forest is the exclusive licensee of the patent for Bystolic-brand nebivolol hydrochloride tablets. Forest said the various ANDAs filed by Hetero and the others — to make generic-version tablets in 2.5-, 5-, 10- and 20-milligram doses — were far too early, since the drug was not set to expire until December 2021.
When will Celgene’s key patents expire?
Drugmakers are constantly developing new medicines to help hedge the losses in revenues due to patent expirations.
When does drug patent expire?
Since the company applies for a patent long before the clinical trial to assess a drug’s safety and efficacy has commenced, the effective patent period after the drug has finally received approval is often around seven to twelve years. Once the patent has expired, the drug can be manufactured and sold by other companies.
